Upgrade to SI Premium - Free Trial

Biohaven Pharmaceutical Holding (BHVN) PT Raised to $140 at Cowen

August 9, 2021 10:49 AM
Cowen analyst Ken Cacciatore raised the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $140.00 (from $130.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles